InnovAge Holding Corp. Common Stock (INNV) is a publicly traded Healthcare sector company. As of July 28, 2026, INNV trades at $11.50 with a market cap of $1.57B and a P/E ratio of -144.38. INNV moved -0.87% today. Year to date, INNV is +121.19%; over the trailing twelve months it is +198.96%. Its 52-week range spans $2.60 to $12.64. Analyst consensus is neutral with an average price target of $0.00. Rallies surfaces INNV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for INNV combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $11.50 |
| Market Cap | $1.57B |
| P/E Ratio | -144.38 |
| EPS | $-0.08 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.64 |
| 52-Week Low | $2.60 |
| Volume | 188.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $949.17M |
| Net Income | $-15.47M |
| Gross Margin | 21.75% |
2 analysts cover INNV: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $0.00.